Subscribe to receive this FREE daily commentary directly in your email
Don’t forget to subscribe to get his report sent daily to your email for Free. It includes the sector scorecard and links to other great articles we write.Â
Biotech
Biotech share, rose slightly today and we can see from the chart below, the ETF, has played a game of fill the gap. The gap was previously created back on July 19. The hourly chart shows that the ETF has now bottomed nicely and appears to be rounding higher.
IBB by Scorpio244 on TradingView.com
Get our one-pager to learn more about Mott Capital
Technology
Technology stocks continue to trend higher as well, with a well defined regression channel. The trend line from the February. lows is still very much in tact.
XLK by Scorpio244 on TradingView.com
We write research for institutions or individuals at reasonable rates.  With reports starting at just $125. Find out more.Â
S&P 500
The S&P 500 continues to trace out along the February/Brexit lows, but the trend line continues to act as resistance. In fact, the recent setup in the triangle, tells us the index maybe getting to breakout shortly.
S&P 500 With Triangle by Scorpio244 on TradingView.com
Disclaimer: Mott Capital Management, LLC is a registered investment adviser. Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and unless otherwise stated, are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Upon request, the advisor will provide a list of all recommendation made during the past twelve months. Past performance is not indicative of future performance.
Subscribe to receive this FREE daily commentary directly in your email
Charts used with the permission of Bloomberg Finance L.P. This report contains independent commentary to be used for informational and educational purposes only. Michael Kramer is a member and investment adviser representative with Mott Capital Management. Mr. Kramer is not affiliated with this company and does not serve on the board of any related company that issued this stock. All opinions and analyses presented by Michael Kramer in this analysis or market report are solely Michael Kramer’s views. Readers should not treat any opinion, viewpoint, or prediction expressed by Michael Kramer as a specific solicitation or recommendation to buy or sell a particular security or follow a particular strategy. Michael Kramer’s analyses are based upon information and independent research that he considers reliable, but neither Michael Kramer nor Mott Capital Management guarantees its completeness or accuracy, and it should not be relied upon as such. Michael Kramer is not under any obligation to update or correct any information presented in his analyses. Mr. Kramer’s statements, guidance, and opinions are subject to change without notice. Past performance is not indicative of future results. Neither Michael Kramer nor Mott Capital Management guarantees any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment commentary presented in this analysis. Strategies or investments discussed may fluctuate in price or value. Investments or strategies mentioned in this analysis may not be suitable for you. This material does not consider your particular investment objectives, financial situation, or needs and is not intended as a recommendation appropriate for you. You must make an independent decision regarding investments or strategies in this analysis. Upon request, the advisor will provide a list of all recommendations made during the past twelve months. Before acting on information in this analysis, you should consider whether it is suitable for your circumstances and strongly consider seeking advice from your own financial or investment adviser to determine the suitability of any investment.